SE303507B - - Google Patents

Info

Publication number
SE303507B
SE303507B SE27667A SE27667A SE303507B SE 303507 B SE303507 B SE 303507B SE 27667 A SE27667 A SE 27667A SE 27667 A SE27667 A SE 27667A SE 303507 B SE303507 B SE 303507B
Authority
SE
Sweden
Application number
SE27667A
Inventor
A Gagneux
F Haefliger
C Eugster
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Publication of SE303507B publication Critical patent/SE303507B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE27667A 1963-12-06 1967-01-09 SE303507B (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1495463A CH427803A (de) 1963-12-06 1963-12-06 Verfahren zur Herstellung eines neuen Isoxazolderivates

Publications (1)

Publication Number Publication Date
SE303507B true SE303507B (xx) 1968-09-02

Family

ID=4405150

Family Applications (3)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (xx) 1963-12-06 1964-12-04
SE27767A SE304513B (xx) 1963-12-06 1967-01-09
SE27667A SE303507B (xx) 1963-12-06 1967-01-09

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (xx) 1963-12-06 1964-12-04
SE27767A SE304513B (xx) 1963-12-06 1967-01-09

Country Status (12)

Country Link
US (1) US3242190A (xx)
AT (2) AT249054B (xx)
BE (1) BE656759A (xx)
CH (1) CH427803A (xx)
DE (1) DE1445848A1 (xx)
DK (4) DK108169C (xx)
ES (5) ES306817A1 (xx)
FR (2) FR1427775A (xx)
GB (1) GB1034939A (xx)
IL (1) IL22568A (xx)
NL (1) NL6414138A (xx)
SE (3) SE301652B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001774A1 (en) * 1982-10-26 1984-05-10 Cheminova As A process for the preparation of 3-hydroxy-isoxazolole

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130992C (xx) * 1964-09-14
WO2002043762A2 (en) 2000-11-30 2002-06-06 Pfizer Products Inc. Combination of gaba agonists and sorbitol dehydrogenase inhibitors
EP1337272A2 (en) 2000-11-30 2003-08-27 Pfizer Products Inc. Combination of gaba agonists and aldose reductase inhibitors
CA2525366A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
AU2004305563C1 (en) 2003-12-11 2011-07-07 Sunovion Pharmaceuticals Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
WO2005082372A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. COMBINATION OF γ-AMINOBUTYRIC ACID MODULATORS AND 5-HT 1B RECEPTOR ANTAGONISTS
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
CA2625210A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
WO2007104035A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2009002496A (es) * 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
EP2066355A2 (en) * 2006-09-19 2009-06-10 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001774A1 (en) * 1982-10-26 1984-05-10 Cheminova As A process for the preparation of 3-hydroxy-isoxazolole

Also Published As

Publication number Publication date
ES306820A1 (es) 1965-05-16
AT250348B (de) 1966-11-10
SE301652B (xx) 1968-06-17
FR4139M (xx) 1966-05-02
ES306816A1 (es) 1965-05-16
DK108169C (da) 1967-10-02
IL22568A (en) 1968-04-25
BE656759A (xx) 1965-06-08
FR1427775A (fr) 1966-02-11
NL6414138A (xx) 1965-06-07
ES306819A1 (es) 1965-05-16
ES306818A1 (es) 1965-05-16
SE304513B (xx) 1968-09-30
AT249054B (de) 1966-09-26
DK106797C (da) 1967-03-20
CH427803A (de) 1967-01-15
US3242190A (en) 1966-03-22
ES306817A1 (es) 1965-05-16
DE1445848A1 (de) 1968-11-21
DK106796C (da) 1967-03-20
DK106733C (da) 1967-03-13
GB1034939A (en) 1966-07-06

Similar Documents

Publication Publication Date Title
AR142945A1 (xx)
AT260747B (xx)
BE627012A (xx)
BE627023A (xx)
BE623117A (xx)
BE643836A (xx)
BE643807A (xx)
BE643795A (xx)
BE643564A (xx)
BE643451A (xx)
BE637683A (xx)
BE636825A (xx)
BE631154A (xx)
BE31062A (xx)
BE462764A (xx)
BE465565A (xx)
BE630020A (xx)
BE627172A (xx)
BE627151A (xx)
BE627145A (xx)
BE621232A (xx)
BE627083A (xx)
BE627025A (xx)
BE621517A (xx)
BE627141A (xx)